Literature DB >> 25939487

Declining liver graft quality threatens the future of liver transplantation in the United States.

Eric S Orman1,2, Maria E Mayorga3, Stephanie B Wheeler4, Rachel M Townsley3, Hector H Toro-Diaz5, Paul H Hayashi1, A Sidney Barritt1.   

Abstract

National liver transplantation (LT) volume has declined since 2006, in part because of worsening donor organ quality. Trends that degrade organ quality are expected to continue over the next 2 decades. We used the United Network for Organ Sharing (UNOS) database to inform a 20-year discrete event simulation estimating LT volume from 2010 to 2030. Data to inform the model were obtained from deceased organ donors between 2000 and 2009. If donor liver utilization practices remain constant, utilization will fall from 78% to 44% by 2030, resulting in 2230 fewer LTs. If transplant centers increase their risk tolerance for marginal grafts, utilization would decrease to 48%. The institution of "opt-out" organ donation policies to increase the donor pool would still result in 1380 to 1866 fewer transplants. Ex vivo perfusion techniques that increase the use of marginal donor livers may stabilize LT volume. Otherwise, the number of LTs in the United States will decrease substantially over the next 15 years. In conclusion, the transplant community will need to accept inferior grafts and potentially worse posttransplant outcomes and/or develop new strategies for increasing organ donation and utilization in order to maintain the number of LTs at the current level.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25939487      PMCID: PMC4566853          DOI: 10.1002/lt.24160

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  45 in total

1.  Donation after cardiac death liver transplantation: predictors of outcome.

Authors:  A K Mathur; J Heimbach; D E Steffick; C J Sonnenday; N P Goodrich; R M Merion
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

2.  Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.

Authors:  Jonathan Karnon
Journal:  Health Econ       Date:  2003-10       Impact factor: 3.046

3.  A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

Authors:  Steven M Shechter; Cindy L Bryce; Oguzhan Alagoz; Jennifer E Kreke; James E Stahl; Andrew J Schaefer; Derek C Angus; Mark S Roberts
Journal:  Med Decis Making       Date:  2005 Mar-Apr       Impact factor: 2.583

4.  3D-printed biological organs: medical potential and patenting opportunity.

Authors:  Seung-Schik Yoo
Journal:  Expert Opin Ther Pat       Date:  2015-02-24       Impact factor: 6.674

Review 5.  Expanding the donor pool to increase renal transplantation.

Authors:  Bernard Cohen; Jacqueline M Smits; Bernadette Haase; Guido Persijn; Yves Vanrenterghem; Ulrich Frei
Journal:  Nephrol Dial Transplant       Date:  2004-11-02       Impact factor: 5.992

6.  Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.

Authors:  Mauricio Gabrielli; Fabrizio Moisan; Marcela Vidal; Ignacio Duarte; Macarena Jiménez; Guillermo Izquierdo; Pilar Domínguez; Javier Méndez; Alejandro Soza; Carlos Benitez; Rosa Pérez; Marco Arrese; Juan Guerra; Nicolás Jarufe; Jorge Martínez
Journal:  Ann Hepatol       Date:  2012 Nov-Dec       Impact factor: 2.400

7.  Donor selection for adult-to-adult living donor liver transplantation: well begun is half done.

Authors:  Amit Sharma; April Ashworth; Martha Behnke; Adrian Cotterell; Marc Posner; Robert A Fisher
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

8.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

9.  Technique of subnormothermic ex vivo liver perfusion for the storage, assessment, and repair of marginal liver grafts.

Authors:  Jan M Knaak; Vinzent N Spetzler; Nicolas Goldaracena; Kristine S Louis; Nazia Selzner; Markus Selzner
Journal:  J Vis Exp       Date:  2014-08-13       Impact factor: 1.355

10.  Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.

Authors:  Eric S Orman; A Sidney Barritt; Stephanie B Wheeler; Paul H Hayashi
Journal:  Liver Transpl       Date:  2013-01       Impact factor: 5.799

View more
  40 in total

1.  Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.

Authors:  Kristopher P Croome; Amit K Mathur; David D Lee; Adyr A Moss; Charles B Rosen; Julie K Heimbach; C Burcin Taner
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 2.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

Review 3.  Transplant for the very sick: No limitations in donor quality?

Authors:  Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

4.  Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model.

Authors:  Clifford Akateh; Eliza W Beal; Jung-Lye Kim; Brenda F Reader; Katelyn Maynard; Jay L Zweier; Bryan A Whitson; Sylvester M Black
Journal:  J Surg Res       Date:  2019-02-13       Impact factor: 2.192

5.  Extended criteria donors in liver transplantation-from marginality to mainstream.

Authors:  Amit Nair; Koji Hashimoto
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

6.  Postoperative Elevated Resistive Indices Do Not Predict Hepatic Artery Thrombosis in Extended Criteria Donor Livers.

Authors:  Eric J Siskind; Fauzia Vandermeer; Tamar R Siskind; David A Bruno; Samuel Sultan; Josue Alvarez-Casas; Arielle Stafford; Barton Lane; John C Lamattina; Rolf N Barth; Steven I Hanish
Journal:  Int J Angiol       Date:  2017-03-01

Review 7.  NAFLD and liver transplantation: Current burden and expected challenges.

Authors:  Raluca Pais; A Sidney Barritt; Yvon Calmus; Olivier Scatton; Thomas Runge; Pascal Lebray; Thierry Poynard; Vlad Ratziu; Filomena Conti
Journal:  J Hepatol       Date:  2016-07-30       Impact factor: 25.083

8.  Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition.

Authors:  Xiangdong Wang; Christopher J Walkey; Ana C Maretti-Mira; Lei Wang; Deborah L Johnson; Laurie D DeLeve
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

9.  [High donor age for liver transplantation : Tackling organ scarcity in Germany].

Authors:  S Moosburner; P V Ritschl; L Wiering; J M G V Gassner; R Öllinger; J Pratschke; I M Sauer; N Raschzok
Journal:  Chirurg       Date:  2019-09       Impact factor: 0.955

10.  Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.

Authors:  Zinan Yi; Maria E Mayorga; Eric S Orman; Stephanie B Wheeler; Paul H Hayashi; A Sidney Barritt
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.